Visco Vision Inc. (TPE:6782)
172.00
+1.00 (0.58%)
At close: Dec 3, 2025
Visco Vision Revenue
Visco Vision had revenue of 1.13B TWD in the quarter ending September 30, 2025, with 9.19% growth. This brings the company's revenue in the last twelve months to 4.07B, up 18.05% year-over-year. In the year 2024, Visco Vision had annual revenue of 3.67B with 53.13% growth.
Revenue (ttm)
4.07B
Revenue Growth
+18.05%
P/S Ratio
2.66
Revenue / Employee
n/a
Employees
n/a
Market Cap
10.84B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 3.67B | 1.27B | 53.13% |
| Dec 31, 2023 | 2.40B | -379.85M | -13.68% |
| Dec 31, 2022 | 2.78B | 813.03M | 41.39% |
| Dec 31, 2021 | 1.96B | 438.11M | 28.70% |
| Dec 31, 2020 | 1.53B | 54.37M | 3.69% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Bora Pharmaceuticals Co., LTD. | 21.10B |
| Lotus Pharmaceutical | 18.66B |
| PharmaEssentia | 13.82B |
| Pegavision | 6.90B |
| Center Laboratories | 1.57B |
| Oneness Biotech | 117.33M |
| Polaris Group | 70.83M |
| Lumosa Therapeutics | 42.59M |